Resistance to carbapenems in a leading hospital bacterium hit 69% in 2025, as lawyers report a rise in malpractice cases linked to drug-resistant infections
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.
